We are live on !
Find out more
Bleichroeder Portfolio holdings
AUM
$1.02B
Turnover
33.63%
1-Year Est. Return
33%
This Fund
S&P 500
This Quarter Est. Return
+9.08%
1 Year Est. Return
+33%
3 Year Est. Return
+222.49%
5 Year Est. Return
+219.92%
10 Year Est. Return
–
AUM
$663M
AUM Growth
+$70.5M
(+12%)
Cap. Flow
+$41.2M
Cap. Flow % of AUM
Cap. Flow %
6.22%
Top 10 Holdings %
Top 10 Hldgs %
59.59%
Holding
99
New
18
Increased
4
Reduced
2
Closed
7
Avg Time Held
0.9
years
Top 10 Avg Time Held
0.9
years
Top 20 Avg Time Held
1
year
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
PACX
Pioneer Merger Corp. Class A Ordinary Share
PACX
|
+$20.9M |
| 2 |
EQRX
EQRx, Inc. Common Stock
EQRX
|
+$10.2M |
| 3 |
iSpecimen
ISPC
|
+$4.32M |
| 4 |
Alliance Entertainment
AENT
|
+$3.89M |
| 5 |
Marinus Pharmaceuticals, Inc
MRNS
|
+$3.74M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Filana Therapeutics
FLNA
|
+$6.7M |
| 2 |
ADRA.U
Adara Acquisition Corp Units
ADRA.U
|
+$3.97M |
| 3 |
DISH
DISH Network Corp.
DISH
|
+$2.81M |
| 4 |
BRPMU
B. Riley Principal 150 Merger Corp. Unit
BRPMU
|
+$2.25M |
| 5 |
GeneDx Holdings
WGS
|
+$1.49M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 26% |
| 2 | Industrials | 13.45% |
| 3 | Miscellaneous | 12.78% |
| 4 | Consumer Discretionary | 11.5% |
| 5 | Financials | 11.07% |
Similar funds
KL
Bleichroeder's Q2 2021 Portfolio in Review
As of Q2 2021, Bleichroeder held 99 positions worth $663M, up 12% from $592M the previous quarter. Its ten largest holdings account for 60% of the portfolio.
Bleichroeder deployed $41.2M of net new capital in Q2 2021, opening 18 new positions and adding to 4 existing holdings. Its largest new stake was Pioneer Merger Corp. Class A Ordinary Share: 2,125,000 shares worth $21.1M.
By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Industrials and Miscellaneous.
On the sell side, the largest reduction was Filana Therapeutics, an estimated $6.7M trimmed.
- Bleichroeder's largest Q2 2021 buy was Pioneer Merger Corp. Class A Ordinary Share: 2,125,000 shares worth $21.1M.
- Bleichroeder added most to Marinus Pharmaceuticals, Inc in Q2 2021, an estimated $3.74M increase.
- Bleichroeder's biggest Q2 2021 reduction was Filana Therapeutics, cutting an estimated $6.7M.
- Bleichroeder fully exited Adara Acquisition Corp Units in Q2 2021, selling an estimated $3.97M.
- Bleichroeder's ten largest holdings make up 60% of its $663M portfolio in Q2 2021.
- Bleichroeder opened 18 new positions and closed 7 in Q2 2021.
- Bleichroeder's portfolio value rose 12% quarter-over-quarter to $663M.
Based on Bleichroeder's 13F filing for Q2 2021, filed 16 Aug 2021.